Saphnelo is a first-in-class type I interferon receptor antibody shown to reduce overall disease activity in patients with systemic lupus erythematosus (Form 6-K)
Get instant alerts when news breaks on your stocks. Claim your 1-week free trial to StreetInsider Premium here. Shelton, CT, July 26, 2022 (GLOBE NEWSWIRE) […]
SAO PAULO–(BUSINESS WIRE)–Fitch Ratings has affirmed the ratings of Construtora Andrade Gutierrez S.A. (CAG) and related issuances as follows: CAG –Foreign Currency Issued Default Rating […]
Mobile giants EE have been revealed as the best performing network in OpenSignal, the app which monitors network speeds, has been crunching the numbers to […]
Spokesperson. Good morning and welcome to this presentation of the European Commission’s 2014 autumn economic forecast. This forecast has been prepared by the Commission’s Economic […]